Keith R Olson

Title: Keith R Olson: Innovator in Receptor Tyrosine Kinase Assays

Introduction

Keith R Olson is a notable inventor based in the United States. He has made significant contributions to the field of biochemistry, particularly in the area of receptor tyrosine kinases (RTKs). His innovative methods for detecting phosphorylation of RTKs have the potential to advance research in cellular signaling and cancer biology.

Latest Patents

Keith R Olson currently holds no patents. However, his work on receptor tyrosine kinase assays is noteworthy. The method he developed employs cells that contain two fusion products: an RTK fused to a small fragment of β-galactosidase and a phosphotyrosine binding peptide fused to the large fragment of β-galactosidase. This innovative approach allows for the detection of phosphorylation events, which are crucial for understanding RTK activation.

Career Highlights

Keith R Olson is associated with Eurofins Discoverx Corporation, where he continues to contribute to advancements in biochemical assays. His expertise in receptor tyrosine kinases has positioned him as a valuable asset in the field of drug discovery and development.

Collaborations

Some of his notable coworkers include Wei Feng and William Raab. Their collaborative efforts in research and development have further enhanced the capabilities of the projects they work on.

Conclusion

Keith R Olson's contributions to receptor tyrosine kinase assays exemplify the importance of innovation in scientific research. His work has the potential to impact various fields, including cancer research and therapeutic development.